Adolescent contraception: Review and guidance for pediatric clinicians

Current Problems in Pediatric and Adolescent Health Care

Volumn 42, Issue 9, 2012, Pages 221-263

  Hartman, Lauren B ^a   Monasterio, Erica ^a   Hwang, Loris Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; AMIODARONE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; BOSENTAN; CARBAMAZEPINE; CISAPRIDE; CLARITHROMYCIN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETONOGESTREL; FELBAMATE; GESTAGEN; GRISEOFULVIN; HYPERICUM PERFORATUM EXTRACT; ITRACONAZOLE; KETOCONAZOLE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NEFAZODONE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; RIFAMPICIN; RITONAVIR; TELITHROMYCIN; TOPIRAMATE; UNINDEXED DRUG; VORICONAZOLE;

ACNE; ADOLESCENT DEVELOPMENT; ADOLESCENT HEALTH; ADOLESCENT PREGNANCY; AMENORRHEA; ANAPHYLAXIS; ANEMIA; BONE DENSITY; BREAST CYST; BREAST FEEDING; CANCER RISK; CHRONIC DISEASE; CONTRACEPTION; CONTRACEPTIVE DEVICE; DECISION MAKING; DEPRESSION; DISABILITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSMENORRHEA; ECTOPIC PREGNANCY; EMERGENCY CONTRACEPTION; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FATIGUE; FRACTURE; HEADACHE; HEALTH CARE ACCESS; HIRSUTISM; HORMONAL CONTRACEPTION; HUMAN; HYPERANDROGENISM; INFERTILITY; INTRAUTERINE CONTRACEPTIVE DEVICE; IRON DEFICIENCY ANEMIA; MASTALGIA; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENTAL INSTABILITY; MOOD DISORDER; MORTALITY; NULLIPARA; OLIGOMENORRHEA; ORAL CONTRACEPTION; OVARY CANCER; OVARY CYST; PAIN; PARENT COUNSELING; PATIENT COMPLIANCE; PATIENT COUNSELING; PELVIC INFLAMMATORY DISEASE; PREGNANCY RATE; REVIEW; RISK FACTOR; SEIZURE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SICKLE CELL CRISIS; SIDE EFFECT; THROMBOSIS; TREATMENT CONTRAINDICATION; UTERINE CERVIX CANCER; VAGINA RING; VENOUS THROMBOEMBOLISM; WEIGHT CHANGE; WEIGHT GAIN;

EID: 84866103098     PISSN: 15385442     EISSN: 15383199     Source Type: Journal    
DOI: 10.1016/j.cppeds.2012.05.001     Document Type: Article

References (246)

1. D.K. Eaton, L. Kann, S. Kinchen, S. Shanklin, J. Ross, J. Hawkins Youth risk behavior surveillance - United states, 2009 MMWR Surveill Summ 59 2010 1 142
2. L.M. Henry-Reid, K.G. O'Connor, J.D. Klein, E. Cooper, P. Flynn, D.C. Futterman Current pediatrician practices in identifying high-risk behaviors of adolescents Pediatrics 125 2010 e741 e747
3. Centers for Disease Control and Prevention (CDC) Vital signs: Teen pregnancy - United states, 1991-2009 MMWR Morb Mortal Wkly Rep 60 2011 414 420
4. H. Weinstock, S. Berman, W. Cates Jr Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000 Perspect Sex Reprod Health 36 2004 6 10
5. S. Davis Pregnancy in adolescents Pediatr Clin North Am 36 1989 665 680r
6. T.O. Scholl, M.L. Hediger, D.H. Belsky Prenatal care and maternal health during adolescent pregnancy: A review and meta-analysis J Adolesc Health 15 1994 444 456
7. R.L. Coley, P.L. Chase-Lansdale Adolescent pregnancy and parenthood Recent evidence and future directions Am Psychol 53 1998 152 166
8. B.L. O'Donnell, C.R. O'Donnell, A. Stueve Early sexual initiation and subsequent sex-related risks among urban minority youth: The reach for health study Fam Plann Perspect 33 2001 268 275
9. C.D. Houck, N.R. Nugent, C.M. Lescano, A. Peters, L.K. Brown Sexual abuse and sexual risk behavior: Beyond the impact of psychiatric problems J Pediatr Psychol 35 2010 473 483
10. S.J. Ventura, J.C. Abma, W.D. Mosher, S.K. Henshaw Estimated pregnancy rates for the united states, 1990-2005: An update Natl Vital Stat Rep 58 2009 1 14
11. T.R. Raine, A. Foster-Rosales, U.D. Upadhyay One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives Obstet Gynecol 117 2011 363 371
12. K. Kaye, K. Suellentrop, C. Sloup The fog zone: How misperceptions, magical thinking, and ambivalence put young adults at risk for unplanned pregnancy 2009 The National Campaign to Prevent Teen and Unplanned Pregnancy Washington, DC
13. K. Kost, J.D. Forrest, S. Harlap Comparing the health risks and benefits of contraceptive choices Fam Plann Perspect 23 1991 54 61
14. X. Chen, D.A. Murphy, S. Naar-King, J.T. Parsons Adolescent Nedicine Trials Network for HIV/AIDS Interventions A clinic-based motivational intervention improves condom use among subgroups of youth living with HIV J Adolesc Health 49 2011 193 198
15. D.T. Lai, K. Cahill, Y. Qin, J.L. Tang Motivational interviewing for smoking cessation Cochrane Database Syst Rev 2010 CD006936
16. S. Gates, J. McCambridge, L.A. Smith, D.R. Foxcroft Interventions for prevention of drug use by young people delivered in non-school settings Cochrane Database Syst Rev 2006 CD005030
17. L.M. Lopez, E.E. Tolley, D.A. Grimes, M. Chen-Mok Theory-based strategies for improving contraceptive use: A systematic review Contraception 79 2009 411 417
18. S.J. Erickson, M. Gerstle, S.W. Feldstein Brief interventions and motivational interviewing with children, adolescents, and their parents in pediatric health care settings: A review Arch Pediatr Adolesc Med 159 2005 1173 1180
19. Sex Smarts Kaiser Family Foundation http://www.kff.org/entpartnerships/ upload/Sex-Smarts-Birth-Control-and-Protection-Bruchure Accessed October 2011
20. J.A. Lehrer, R. Pantell, K. Tebb, M.A. Shafer Forgone health care among U.S. adolescents: Associations between risk characteristics and confidentiality concern J Adolesc Health 40 2007 218 226
21. State policies in brief: An overview of minors' consent laws Guttmacher Institute http://www.guttmacher.org/statecenter/spibs/spib-OMCL.pdf Accessed October 2011
22. A. English Sexual and reproductive health care for adolescents: Legal rights and policy challenges Adolesc Med State Art Rev 18 2007 571 581 viii-ix
23. M.B. Short, J.K. Yates, F. Biro, S.L. Rosenthal Parents and partners: Enhancing participation in contraception use J Pediatr Adolesc Gynecol 18 2005 379 383
24. L.D. Watt Pregnancy prevention in primary care for adolescent males J Pediatr Health Care 15 2001 223 228
25. R.L. Williams, J.D. Fortenberry Update on adolescent condom use Curr Opin Obstet Gynecol 23 2011 350 354
26. M. Hovell, E. Blumberg, C. Sipan Skills training for pregnancy and AIDS prevention in anglo and latino youth J Adolesc Health 23 1998 139 149
27. J.G. Rosenberger, D.L. Bell, K.R. McBride, J.D. Fortenberry, M.A. Ott Condoms and developmental contexts in younger adolescent boys Sex Transm Infect 86 2010 400 403
28. G. Bártfai Emergency contraception in clinical practice: Global perspectives Int J Gynaecol Obstet 70 2000 49 58
29. C.C. Harper, B.A. Brown, A. Foster-Rosales, T.R. Raine Hormonal contraceptive method choice among young, low-income women: How important is the provider? Patient Educ Couns 81 2010 349 354
30. G.S. Sucato, S.K. Bhatt, P.J. Murray, M.A. Ott Transdermal contraception as a model for adolescent use of new methods J Adolesc Health 49 2011 357 362
31. V. Halpern, L.M. Lopez, D.A. Grimes, M.F. Gallo Strategies to improve adherence and acceptability of hormonal methods of contraception Cochrane Database Syst Rev 2011 CD004317
32. E. Miller, M.R. Decker, H.L. McCauley Pregnancy coercion, intimate partner violence and unintended pregnancy Contraception 81 2010 316 322
33. S.A. Sanders, J.M. Reinisch Would you say you "had sex" if... ? JAMA 281 1999 275 277
34. M.A. Schuster, R.M. Bell, D.E. Kanouse The sexual practices of adolescent virgins: Genital sexual activities of high school students who have never had vaginal intercourse Am J Public Health 86 1996 1570 1576
35. B. Albert With One Voice 2010: America's Adults And Teens Sound Off About Teen Pregnancy The National Campaign to Prevent Teen and Unwanted Pregnancy Web site 2011
36. W.D. Manning, M.A. Longmore, P.C. Giordano The relationship context of contraceptive use at first intercourse Fam Plann Perspect 32 2000 104 110
37. J.C. Abma, G.M. Martinez, C.E. Copen National Center for Health Statistics Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, National Survey of Family Growth 2006-2008 Vital Health Stat 23 2010 30
38. L. Neinstein, C. Gordon, D. Katzman, D. Rosen, E. Woods Adolescent Health Care: A Practical Guide 5th edn. 2008 Lippincott Williams & Wilkins Philadelphia, PA
39. H. Brückner, P. Bearman After the promise: The STD consequences of adolescent virginity pledges J Adolesc Health 36 2005 271 278
40. J. Santelli, M.A. Ott, M. Lyon, J. Rogers, D. Summers Abstinence-only education policies and programs: A position paper of the society for adolescent medicine J Adolesc Health 38 2006 83 87
41. S.M. Edwards, M. Zieman, K. Jones, A. Diaz, C. Robilotto, C. Westhoff Initiation of oral contraceptives - Start now! J Adolesc Health 43 2008 432 436
42. C. Westhoff, S. Heartwell, S. Edwards Initiation of oral contraceptives using a quick start compared with a conventional start: A randomized controlled trial Obstet Gynecol 109 2007 1270 1276
43. M.B. Bracken Oral contraception and congenital malformations in offspring: A review and meta-analysis of the prospective studies Obstet Gynecol 76 1990 552 557
44. A.L. Nelson, T. Katz Initiation and continuation rates seen in 2-year experience with same day injections of DMPA Contraception 75 2007 84 87
45. A.S. Murthy, M.D. Creinin, B. Harwood, C.A. Schreiber Same-day initiation of the transdermal hormonal delivery system (Contraceptive patch) versus traditional initiation methods Contraception 72 2005 333 336
46. J.E. Schafer, L.M. Osborne, A.R. Davis, C. Westhoff Acceptability and satisfaction using quick start with the contraceptive vaginal ring versus an oral contraceptive Contraception 73 2006 488 492
47. The Center for Reproductive Health Education in Family Medicine (RHEDI) Quick Start Algorithm http://www.rhedi.org/contraception/quick-start-algorithm. php Accessed 2011
48. Centers for Disease Control and Prevention (CDC) U Smedical eligibility criteria for contraceptive use, 2010 MMWR Recomm Rep 59 RR-4 2010 1 86
49. J.O. Prochaska, J.C. Norcross, C.C. Diclemente Changing for Good 1994 Avon Books New York
50. American College of Obstetricians and Gynecologists ACOG Committee opinion no. 463: Cervical cancer in adolescents: Screening, evaluation, and management Obstet Gynecol 116 2 Pt 1 2010 469 472
51. A.B. Moscicki, J.T. Cox Practice improvement in cervical screening and management (PICSM): Symposium on management of cervical abnormalities in adolescents and young women J Low Genit Tract Dis 14 2010 73 80
52. H. von Hertzen, G. Piaggio, J. Ding, J. Chen, S. Song, G. Bártfai Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: A WHO multicentre randomised trial Lancet 360 2002 1803 1810
53. A.O. Arowojolu, I.A. Okewole, A.O. Adekunle Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians Contraception 66 2002 269 273
54. M. Durand, M. del Carmen Cravioto, E.G. Raymond, O. Durán- Sánchez, M. De la Luz Cruz-Hinojosa, A. Castell-Rodríguez On the mechanisms of action of short-term levonorgestrel administration in emergency contraception Contraception 64 2001 227 234
55. L. Marions, K. Hultenby, I. Lindell, X. Sun, B. Ståbi, K. Gemzell Danielsson Emergency contraception with mifepristone and levonorgestrel: Mechanism of action Obstet Gynecol 100 2002 65 71
56. L. Marions, S.Z. Cekan, M. Bygdeman, K. Gemzell-Danielsson Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function Contraception 69 2004 373 377
57. H.B. Croxatto, M.E. Ortiz, A.L. Müller Mechanisms of action of emergency contraception Steroids 68 2003 1095 1098
58. H.B. Croxatto Mechanisms that explain the contraceptive action of progestin implants for women Contraception 65 2002 21 27
59. A. Glasier Emergency postcoital contraception N Engl J Med 337 1997 1058 1064
60. K. Gemzell-Danielsson, L. Marions Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception Hum Reprod Update 10 2004 341 348
61. G. Piaggio, H. von Hertzen, D.A. Grimes, P.F. Van Look Timing of emergency contraception with levonorgestrel or the yuzpe regimen Task force on postovulatory methods of fertility regulation Lancet 353 1999 721
62. A.F. Glasier, S.T. Cameron, P.M. Fine Ulipristal acetate versus levonorgestrel for emergency contraception: A randomised non-inferiority trial and meta-analysis Lancet 375 2010 555 562
63. P. Fine, H. Mathe, S. Ginde, V. Cullins, J. Morfesis, E. Gainer Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception Obstet Gynecol 115 2 Pt 1 2010 257 263
64. World Health Organization (WHO), Fact sheet no. 244: Emergency Contraction. Revised October 2005, Accessed 2011.
65. K.M. Feldhaus A 21st-century challenge: Improving the care of the sexual assault victim Ann Emerg Med 39 2002 653 655
66. A. Norris Turner, C. Ellertson How safe is emergency contraception? Drug Saf 25 2002 695 706
67. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception Task Force on Postovulatory Methods of Fertility Regulation Lancet 352 1998 428 433
68. U.S. Food and Drug Administration (FDA): Updated FDA Action on Plan B (levonorgestrel) Tablets 2009 Accessed 2011
69. S.A. Cohen Objections, confusion among pharmacists threaten access to emergency contraception Guttmacher Rep Public Policy 2 1999 1 3
70. T.R. Raine, C.C. Harper, C.H. Rocca Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: A randomized controlled trial JAMA 293 2005 54 62
71. V. Halpern, E.G. Raymond, L.M. Lopez Repeated use of pre- and postcoital hormonal contraception for prevention of pregnancy Cochrane Database Syst Rev 2010 CD007595
72. A.A. Yuzpe, H.J. Thurlow, I. Ramzy, J.I. Leyshon Post coital contraception - A pilot study J Reprod Med 13 1974 53 58
73. The Emergency Contraception Website http://NOT-2-Late.com http://.ec.princeton.edu/questions/dose.html Accessed April 2011
74. J. Lippes, T. Malik, H.J. Tatum The postcoital copper-T Adv Plan Parent 11 1976 24 29
75. L. Zhou, B. Xiao Emergency contraception with multiload cu-375 SL IUD: A multicenter clinical trial Contraception 64 2001 107 112
76. S. Wu, E.M. Godfrey, D. Wojdyla, J. Dong, J. Cong, C. Wang Copper T380A intrauterine device for emergency contraception: A prospective, multicentre, cohort clinical trial BJOG 117 2010 1205 1210
77. J. Trussell Contraceptive efficacy R. Hatcher, J. Trussell, A. Nelson, W. Cates, F. Stewart, D. Kowal, Contraceptive Technology 19th edn. 2008 New York, NY
78. F.L. Sonenstein, L. Ku, L.D. Lindberg, C.F. Turner, J.H. Pleck Changes in sexual behavior and condom use among teenaged males: 1988 to 1995 Am J Public Health 88 1998 956 959
79. M.F. Gallo, D.A. Grimes, L.M. Lopez, K.F. Schulz Non-latex versus latex male condoms for contraception Cochrane Database Syst Rev 2006 CD003550
80. J.A. Woods, S. Lambert, T.A. Platts-Mills, D.B. Drake, R.F. Edlich Natural rubber latex allergy: Spectrum, diagnostic approach, and therapy J Emerg Med 15 1997 71 85
81. P.A. Cavazos-Rehg, M.J. Krauss, E.L. Spitznagel, M. Schootman, J.F. Peipert, L.B. Cottler Type of contraception method used at last intercourse and associations with health risk behaviors among US adolescents Contraception 82 2010 549 555
82. J. Manlove, E. Ikramullah, E. Terry-Humen Condom use and consistency among male adolescents in the united states J Adolesc Health 43 2008 325 333
83. L. Ku, F.L. Sonenstein, J.H. Pleck The dynamics of young men's condom use during and across relationships Fam Plann Perspect 26 1994 246 251
84. R. Klein, K. Struble U.S. Food and Drug Administration (FDA): FDA approval of the FC2 Female Condom 2009 Accessed 2011
85. M. Beksinska, J. Smit, Z. Mabude, G. Vijayakumar, C. Joanis Performance of the reality polyurethane female condom and a synthetic latex prototype: A randomized crossover trial among South African women Contraception 73 2006 386 393
86. W. Cates Jr, E.G. Raymond Vaginal Barriers and Spermacides 19th edn. 2008 Ardent Media New York, NY 317
87. J.C. Abma, G.M. Martinez, W.D. Mosher, B.S. Dawson Teenagers in the united states: Sexual activity, contraceptive use, and childbearing, 2002 Vital Health Stat 24 2002 1 48 23
88. S. Marshall, P. Giblin, P. Simpson, A. Backos Adolescent girls' perception and experiences with the reality female condom J Adolesc Health 31 2002 5 6
89. J. Trussell, K. Sturgen, J. Strickler, R. Dominik Comparative contraceptive efficacy of the female condom and other barrier methods Fam Plann Perspect 26 1994 66 72
90. A.L. Nelson, L. Neinstein Combined hormonal contraceptives L. Neinstein, C. Gordon, D. Katzman, D. Rosen, E. Woods, Adolescent Health Care: A Practical Guide 5th edn. 2008 Lippincott Williams & Wilkins Philadelphia
91. U.S. Food and Drug Administration (FDA): Lo Loestrin FE 2010 Accessed 2011
92. A. Edelman, M.F. Gallo, M.D. Nichols, J.T. Jensen, K.F. Schulz, D.A. Grimes Continuous versus cyclic use of combined oral contraceptives for contraception: Systematic cochrane review of randomized controlled trials Hum Reprod 21 2006 573 578
93. A.E. Burke, P.D. Blumenthal Successful use of oral contraceptives Semin Reprod Med 19 2001 313 321
94. Committee opinion no. 505: Understanding and using the U.S. medical eligibility criteria for contraceptive use, 2010 Obstet Gynecol 118 2011 754 760
95. J.R. Klein, I.F. Litt Epidemiology of adolescent dysmenorrhea Pediatrics 68 1981 661 664
96. D.R. Mishell Jr Noncontraceptive benefits of oral contraceptives J Reprod Med 38 12 Suppl 1993 1021 1029
97. A. Davis, A. Godwin, J. Lippman, W. Olson, M. Kafrissen Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding Obstet Gynecol 96 2000 913 920
98. A.O. Arowojolu, M.F. Gallo, D.A. Grimes, S.E. Garner Combined oral contraceptive pills for treatment of acne Cochrane Database Syst Rev 2004 CD004425
99. G.P. Redmond, W.H. Olson, J.S. Lippman, M.E. Kafrissen, T.M. Jones, J.L. Jorizzo Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial Obstet Gynecol 89 1997 615 622
100. P. Dewis, P. Petsos, M. Newman, D.C. Anderson The treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol Clin Endocrinol (Oxf) 22 1985 29 36
101. M.R. Laufer Current approaches to optimizing the treatment of endometriosis in adolescents Gynecol Obstet Invest 66 Suppl 1 2008 19 27
102. L. Davis, S.S. Kennedy, J. Moore, A. Prentice Modern combined oral contraceptives for pain associated with endometriosis Cochrane Database Syst Rev 2007 CD001019
103. V. Beral, R. Doll, C. Hermon, R. Peto, G. Reeves Collaborative Group on Epidemiological Studies of Ovarian Cancer Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls Lancet 371 2008 303 314
104. L. Rosenberg, J.R. Palmer, A.G. Zauber, M.E. Warshauer, J.L. Lewis Jr, B.L. Strom A case-control study of oral contraceptive use and invasive epithelial ovarian cancer Am J Epidemiol 139 1994 654 661
105. Combination oral contraceptive use and the risk of endometrial cancer The cancer and steroid hormone study of the centers for disease control and the National Institute of Child Health and Human Development JAMA 257 1987 796 800
106. L.A. Brinton, M.P. Vessey, R. Flavel, D. Yeates Risk factors for benign breast disease Am J Epidemiol 113 1981 203 214
107. S.F. Lanes, B. Birmann, A.M. Walker, S. Singer Oral contraceptive type and functional ovarian cysts Am J Obstet Gynecol 166 1992 956 961
108. M. Vessey, A. Metcalfe, C. Wells, K. McPherson, C. Westhoff, D. Yeates Ovarian neoplasms, functional ovarian cysts, and oral contraceptives Br Med J (Clin Res Ed) 294 1987 1518 1520
109. Cochrane update Oral contraceptives for functional ovarian cysts Obstet Gynecol 114 2009 679 680
110. Effects of contraceptives on hemoglobin and ferritin Task force for epidemiological research on reproductive health, united nations development Programme/United Nations Population Fund/World Health Organization/World Bank special programme of research, development and research training in human reproduction, world health organization, Geneva, Switzerland Contraception 58 1998 262 273
111. J. Conard Biological coagulation findings in third-generation oral contraceptives Hum Reprod Update 5 1999 672 680
112. H. Deguchi, B.N. Bouma, S. Middeldorp, Y.M. Lee, J.H. Griffin Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide J Thromb Haemost 3 2005 935 938
113. N. Sehovic, K.P. Smith Risk of venous thromboembolism with drospirenone in combined oral contraceptive products Ann Pharmacother 44 2010 898 903
114. A. van Hylckama Vlieg, F.M. Helmerhorst, J.P. Vandenbroucke, C.J. Doggen, F.R. Rosendaal The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study BMJ 339 2009 b2921
115. C.C. Trenor 3rd, R.J. Chung, A.D. Michelson, E.J. Neufeld, C.M. Gordon, M.R. Laufer Hormonal contraception and thrombotic risk: A multidisciplinary approach Pediatrics 127 2011 347 357
116. E. Samuelsson, S. Hägg Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users Acta Obstet Gynecol Scand 83 2004 674 681
117. D.B. Petitti, S. Sidney, A. Bernstein, S. Wolf, C. Quesenberry, H.K. Ziel Stroke in users of low-dose oral contraceptives N Engl J Med 335 1996 8 15
118. G.M. Goldbaum, J.S. Kendrick, G.C. Hogelin, E.M. Gentry The relative impact of smoking and oral contraceptive use on women in the united states JAMA 258 1987 1339 1342
119. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multicentre, case-control study WHO collaborative study of cardiovascular disease and steroid hormone contraception Lancet 348 1996 505 510
120. D. Scholes, L. Ichikawa, A.Z. LaCroix, L. Spangler, J.M. Beasley, S. Reed Oral contraceptive use and bone density in adolescent and young adult women Contraception 81 2010 35 40
121. M. Hartard, C. Kleinmond, M. Wiseman, E.R. Weissenbacher, D. Felsenberg, R.G. Erben Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women Bone 40 2007 444 450
122. R.W. Evans, W.J. Becker Migraine and oral contraceptives Headache 46 2006 328 331
123. L. Chasan-Taber, W.C. Willett, J.E. Manson Prospective study of oral contraceptives and hypertension among women in the united states Circulation 94 1996 483 489
124. International Collaboration of Epidemiological Studies of Cervical Cancer P. Appleby, V. Beral, A. Berrington de González, D. Colin, S. Franceschi, A. Goodhill et al. Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies Lancet 370 2007 1609 1621
125. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Collaborative group on hormonal factors in breast cancer Lancet 347 1996 1713 1727
126. P.A. Marchbanks, J.A. McDonald, H.G. Wilson, S.G. Folger, M.G. Mandel, J.R. Daling Oral contraceptives and the risk of breast cancer N Engl J Med 346 2002 2025 2032
127. L. Potter, D. Oakley, E. de Leon-Wong, R. Cañamar Measuring compliance among oral contraceptive users Fam Plann Perspect 28 1996 154 158
128. K. Kost, S. Singh, B. Vaughan, J. Trussell, A. Bankole Estimates of contraceptive failure from the 2002 National Survey of Family Growth Contraception 77 2008 10 21
129. K.O. White, C. Westhoff The effect of pack supply on oral contraceptive pill continuation: A randomized controlled trial Obstet Gynecol 118 2011 615 622
130. R.H. Mattson, J.A. Cramer, P.D. Darney, F. Naftolin Use of oral contraceptives by women with epilepsy JAMA 256 1986 238 240
131. D.J. Back, M.L. Orme Pharmacokinetic drug interactions with oral contraceptives Clin Pharmacokinet 18 1990 472 484
132. J.V. Joshi, U.M. Joshi, G.M. Sankholi A study of interaction of low-dose combination oral contraceptive with ampicillin and metronidazole Contraception 22 1980 643 652
133. J.L. Neely, M. Abate, M. Swinker, R. D'Angio The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone Obstet Gynecol 77 1991 416 420
134. S.D. Hall, Z. Wang, S.M. Huang, M.A. Hamman, N. Vasavada, A.Q. Adigun The interaction between St John's wort and an oral contraceptive Clin Pharmacol Ther 74 2003 525 535
135. M. Zieman, J. Guillebaud, E. Weisberg, G.A. Shangold, A.C. Fisher, G.W. Creasy Contraceptive efficacy and cycle control with the ortho Evra/Evra transdermal system: The analysis of pooled data Fertil Steril 77 2 Suppl 2 2002 S13 S18
136. M.L. Rubinstein, B.L. Halpern-Felsher, C.E. Irwin Jr An evaluation of the use of the transdermal contraceptive patch in adolescents J Adolesc Health 34 2004 395 401
137. Ortho Evra (norelgestromin/ethinyl estradiol transdermal system [Revised] Product Labeling 2006 Ortho-McNeil Pharmaceutical, Inc Raritan, NJ
138. FDA U.S. Food and Drug Administration. FDA updates labeling for Ortho Evra contraceptive patch. Accessed March 2011.
139. S.S. Jick, J.A. Kaye, S. Russmann, H. Jick Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol Contraception 73 2006 223 228
140. S. Jick, J.A. Kaye, L. Li, H. Jick Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol Contraception 76 2007 4 7
141. S.S. Jick, K.W. Hagberg, R.K. Hernandez, J.A. Kaye Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism Contraception 81 2010 16 21
142. D.D. Dore, H. Norman, J. Loughlin, J.D. Seeger Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users Contraception 81 2010 408 413
143. K. Oddsson, B. Leifels-Fischer, N.R. de Melo, D. Wiel-Masson, C. Benedetto, C.H. Verhoeven Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: A 1-year randomized trial Contraception 71 2005 176 182
144. F.H. Stewart, B.A. Brown, T.R. Raine, T.A. Weitz, C.C. Harper Adolescent and young women's experience with the vaginal ring and oral contraceptive pills J Pediatr Adolesc Gynecol 20 2007 345 351
145. Nuva Ring (etonogestrel/ethinyl estradiol vaginal ring) product labeling 2001 Merck & Co., Inc. Whitehouse Sation, NJ
146. L. Miller, C.H. Verhoeven, J. Hout Extended regimens of the contraceptive vaginal ring: A randomized trial Obstet Gynecol 106 2005 473 482
147. M.F. McCann, L.S. Potter Progestin-only oral contraception: A comprehensive review Contraception 50 6 Suppl 1 1994 S1 S195
148. J. Martinez-Manautou, J. Giner-Velasquez, V. Cortes-Gallegos Daily progestogen for contraception: A clinical study Br Med J 2 1967 730 732
149. B.M. Landgren, A. Balogh, M.W. Shin, M. Lindberg, E. Diczfalusy Hormonal effects of the 300 microgram norethisterone (NET) minipill 2. Daily gonadotrophin levels in 43 subjects during a pretreatment cycle and during the second month of NET administration Contraception 20 1979 585 605
150. T. Kim-Björklund, B.M. Landgren, E. Johannisson Morphometric studies of the endometrium, the fallopian tube and the corpus luteum during contraception with the 300 micrograms norethisterone (NET) minipill Contraception 43 1991 459 474
151. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives Results of an international, multicenter, case-control study. World health organization collaborative study of cardiovascular disease and steroid hormone contraception Contraception 57 1998 315 324
152. L.A. Heinemann, A. Assmann, T. DoMinh, E. Garbe Oral progestogen-only contraceptives and cardiovascular risk: Results from the transnational study on oral contraceptives and the health of young women Eur J Contracept Reprod Health Care 4 1999 67 73
153. M.P. Gomes, S.R. Deitcher Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: A clinical review Arch Intern Med 164 2004 1965 1976
154. S.F. Hussain Progestogen-only pills and high blood pressure: Is there an association? A literature review Contraception 69 2004 89 97
155. I.S. Fraser A review of the use of progestogen-only minipills for contraception during lactation Reprod Fertil Dev 3 1991 245 254
156. E.M. Belsey The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use Contraception 38 1988 207 225
157. E. Raymond Progestin-only pills R. Hatcher, J. Trussell, A.L. Nelson, W. Cates, F. Stewart, D. Kowal, Contraceptive technology 19th edn. 2007 Ardent Media, Inc New York
158. C.A. Petta, A. Faundes, T.R. Dunson, M. Ramos, M. DeLucio, D. Faundes Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I Changes in cervical mucus Fertil Steril 69 1998 252 257
159. J. Jain, C. Dutton, A. Nicosia, C. Wajszczuk, F.R. Bode, D.R. Mishell Jr Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera Contraception 70 2004 11 18
160. J. Jain, A.J. Jakimiuk, F.R. Bode, D. Ross, A.M. Kaunitz Contraceptive efficacy and safety of DMPA-SC Contraception 70 2004 269 275
161. B.A. Cromer, R.D. Smith, J.M. Blair, J. Dwyer, R.T. Brown A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception Pediatrics 94 1994 687 694
162. A.B. Goldberg, D.A. Grimes Injectable contraceptives R.A. Hatcher, J. Trussell, A.L. Nelson, W. Cates, F.H. Stewart, D. Kowal, Contraceptive Technology 19th edn. 2007 Ardent Media, Inc New York, NY
163. L. Borgatta, A. Murthy, C. Chuang, L. Beardsley, M.S. Burnhill Pregnancies diagnosed during Depo-Provera use Contraception 66 2002 169 172
164. R.H. Mattson, J.A. Cramer, B.V. Caldwell, B.C. Siconolfi Treatment of seizures with medroxyprogesterone acetate: Preliminary report Neurology 34 1984 1255 1258
165. A.W. Zimmerman, K.R. Holden, E.O. Reiter, A.S. Dekaban Medroxprogesterone acetate in the treatment of seizures associated with menstruation J Pediatr 83 1973 959 963
166. M. de Abood, Z. de Castillo, F. Guerrero, M. Espino, K.L. Austin Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients Contraception 56 1997 313 316
167. J.M. Baeten, P.M. Nyange, B.A. Richardson, L. Lavreys, B. Chohan, H.L. Martin Jr Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study Am J Obstet Gynecol 185 2001 380 385
168. D. Scholes, A.Z. LaCroix, L.E. Ichikawa, W.E. Barlow, S.M. Ott Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception Arch Pediatr Adolesc Med 159 2005 139 144
169. Z. Harel, C.C. Johnson, M.A. Gold, B. Cromer, E. Peterson, R. Burkman Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections Contraception 81 2010 281 291
170. C. Meier, Y.B. Brauchli, S.S. Jick, M.E. Kraenzlin, C.R. Meier Use of depot medroxyprogesterone acetate and fracture risk J Clin Endocrinol Metab 95 2010 4909 4916
171. B.A. Cromer, D. Scholes, A. Berenson, T. Cundy, M.K. Clark, A.M. Kaunitz Depot medroxyprogesterone acetate and bone mineral density in adolescents - The black box warning: A position paper of the society for adolescent medicine J Adolesc Health 39 2006 296 301
172. A.E. Bonny, J. Ziegler, R. Harvey, S.M. Debanne, M. Secic, B.A. Cromer Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method Arch Pediatr Adolesc Med 160 2006 40 45
173. S.A. Mangan, P.G. Larsen, S. Hudson Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate J Pediatr Adolesc Gynecol 15 2002 79 82
174. M.E. Beksinska, J.A. Smit, I. Kleinschmidt, C. Milford, T.M. Farley Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception Contraception 81 2010 30 34
175. N. Gupta, R. O'Brien, L.J. Jacobsen, A. Davis, A. Zuckerman, S. Supran Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: A prospective study J Pediatr Adolesc Gynecol 14 2001 71 76
176. C. Westhoff, C. Truman, D. Kalmuss, L. Cushman, A. Davidson, M. Rulin Depressive symptoms and Depo-Provera Contraception 57 1998 237 240
177. D. Civic, D. Scholes, L. Ichikawa, A.Z. LaCroix, C.K. Yoshida, S.M. Ott Depressive symptoms in users and non-users of depot medroxyprogesterone acetate Contraception 61 2000 385 390
178. D.O. Selo-Ojeme, A. Tillisi, C.C. Welch Anaphylaxis from medroxyprogesterone acetate Obstet Gynecol 103 5 Pt 2 2004 1045 1046
179. P.C. Schwallie, J.R. Assenzo Contraceptive use - Efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days Fertil Steril 24 1973 331 339
180. Z. Harel, F.M. Biro, L.M. Kollar, J.L. Rauh Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant J Adolesc Health 19 1996 118 123
181. Depo-Provera contraceptive injection product labeling. Accessed March 2011.
182. M. Zieman, R.A. Hatcher, C. Cwiak, P.D. Darney, M.D. Creinin, H.R. Stosur Progestin-only contraceptives: Pills, injections, implants Managing Contraception: For Your Pocket 2010 2011
183. R.A. Hatcher, S. Schnare Ask the experts: Progestin-only contraceptives Contracept Technol Update 14 1993 114 115
184. Implanon (etonogestrel implant) product labeling 2011 Merck & Co., Inc. Whitehouse Station, NJ
185. L. Mäkäräinen, A. van Beek, L. Tuomivaara, B. Asplund, H. Coelingh Bennink Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant Fertil Steril 69 1998 714 721
186. I. Sivin Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants Drug Saf 26 2003 303 335
187. S.B. Yisa, A.A. Okenwa, R.P. Husemeyer Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon) J Fam Plann Reprod Health Care 31 2005 67 70
188. M.M. Hidalgo, C. Lisondo, C.T. Juliato, X. Espejo-Arce, I. Monteiro, L. Bahamondes Ovarian cysts in users of Implanon and jadelle subdermal contraceptive implants Contraception 73 2006 532 536
189. E. Raymond Contraceptive implants R. Hatcher, J. Trussell, A. Nelson, W. Cates, F. Stewart, D. Kowal, Contraceptive Technology 19th edn. 2008 Ardent Media, Inc New York, NY
190. S. Díaz Contraceptive implants and lactation Contraception 65 2002 39 46
191. S. Funk, M.M. Miller, D.R. Mishell Jr, D.F. Archer, A. Poindexter, J. Schmidt Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel Contraception 71 2005 319 326
192. S.R. Zheng, H.M. Zheng, S.Z. Qian, G.W. Sang, R.F. Kaper A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant Contraception 60 1999 1 8
193. B. Affandi An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon Contraception 58 6 Suppl 1998 99S 107S
194. J. Bitzer, S. Tschudin, J. Alder Swiss Implanon Study Group Acceptability and side-effects of Implanon in Switzerland: A retrospective study by the Implanon Swiss study group Eur J Contracept Reprod Health Care 9 2004 278 284
195. O. Meirik, I.S. Fraser, C. d'Arcangues WHO Consultation on Implantable Contraceptives for Women Implantable contraceptives for women Hum Reprod Update 9 2003 49 59
196. H. Abdel-Aleem, C. d'Arcangues, K.M. Vogelsong, A.M. Gulmezoglu Treatment of vaginal bleeding irregularities induced by progestin only contraceptives Cochrane Database Syst Rev 2007 CD003449
197. E. Weisberg, M. Hickey, D. Palmer, V. O'Connor, L.A. Salamonsen, J.K. Findlay A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon Hum Reprod 21 2006 295 302
198. E. Espey, T. Ogburn Long-acting reversible contraceptives: Intrauterine devices and the contraceptive implant Obstet Gynecol 117 2011 705 719
199. L.N. Lewis, D.A. Doherty, M. Hickey, S.R. Skinner Implanon as a contraceptive choice for teenage mothers: A comparison of contraceptive choices, acceptability and repeat pregnancy Contraception 81 2010 421 426
200. A new progestin implant (Implanon) for long-term contraception Obstet Gynecol 109 2007 990 991
201. C. Schindlbeck, W. Janni, K. Friese Failure of Implanon contraception in a patient taking carbamazepine for epilepsia Arch Gynecol Obstet 273 2006 255 256
202. R. Beerthuizen, A. van Beek, R. Massai, L. Mäkäräinen, J. Hout, H.C. Bennink Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception Hum Reprod 15 2000 118 122
203. W.D. Mosher, J. Jones Use of contraception in the United States: 1982-2008 Vital Health Stat 23 2010 29
204. ParaGard T 380A prescribing information 2012 Teva Women's Health Sellersville, PA
205. D. Grimes Intrauterine devices (IUDs) R. Hatcher, J. Trussell, A. Nelson, W. Cates, F. Stewart, D. Kowal, Contraceptive Technology 19th edn. 2008 Ardent Media, Inc New York
206. ACOG practice bulletin no. 110: Noncontraceptive uses of hormonal contraceptives Obstet Gynecol 115 2010 206 218
207. D. Hubacher, D.A. Grimes Noncontraceptive health benefits of intrauterine devices: A systematic review Obstet Gynecol Surv 57 2002 120 128
208. J. Zhang, P.J. Feldblum, I.C. Chi, M.G. Farr Risk factors for copper T Iud expulsion: An epidemiologic analysis Contraception 46 1992 427 433
209. Mechanism of action, safety and efficacy of intrauterine devices Report of a WHO scientific group World Health Organ Tech Rep Ser 753 1987 1 91
210. M. Harrison-Woolrych, J. Ashton, D. Coulter Uterine perforation on intrauterine device insertion: Is the incidence higher than previously reported? Contraception 67 2003 53 56
211. I. Sivin Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception Obstet Gynecol 78 1991 291 298
212. A.L. Franks, V. Beral, W. Cates Jr, C.J. Hogue Contraception and ectopic pregnancy risk Am J Obstet Gynecol 163 4 Pt 1 1990 1120 1123
213. D. Hubacher, P.L. Chen, S. Park Side effects from the copper IUD: Do they decrease over time? Contraception 79 2009 356 362
214. Mirena (levonorgestrel-releasing intrauterine system) prescribing information 2009 Bayer HealthCare Pharmaceuticals Berkeley, CA
215. R.A. Lewis, D. Taylor, M.F. Natavio, A. Melamed, J. Felix, D. Mishell Jr Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability Contraception 82 2010 491 496
216. I. Barbosa, S.E. Olsson, V. Odlind, T. Goncalves, E. Coutinho Ovarian function after seven years' use of a levonorgestrel IUD Adv Contracept 11 1995 85 95
217. I. Milsom, K. Andersson, B. Andersch, G. Rybo A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia Am J Obstet Gynecol 164 1991 879 883
218. M. Hidalgo, L. Bahamondes, M. Perrotti, J. Diaz, C. Dantas-Monteiro, C. Petta Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (mirena) up to two years Contraception 65 2002 129 132
219. U.S. Food and Drug Administration (FDA) FDA Approves Additional Use for IUD Mirena to Treat Heavy Menstrual Bleeding in IUD Users 2009 Accessed 2011
220. V. Grigorieva, M. Chen-Mok, M. Tarasova, A. Mikhailov Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas Fertil Steril 79 2003 1194 1198
221. L. Fedele, S. Bianchi, R. Raffaelli, A. Portuese, M. Dorta Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device Fertil Steril 68 1997 426 429
222. E.M. Godfrey, L.M. Memmel, A. Neustadt, M. Shah, A. Nicosia, M. Moorthie Intrauterine contraception for adolescents aged 14-18 years: A multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the copper T 380A Contraception 81 2010 123 127
223. T.M. Farley, M.J. Rosenberg, P.J. Rowe, J.H. Chen, O. Meirik Intrauterine devices and pelvic inflammatory disease: An international perspective Lancet 339 1992 785 788
224. D.A. Grimes Intrauterine device and upper-genital-tract infection Lancet 356 2000 1013 1019
225. K.A. Workowski, S. Berman Centers for Disease Control and Prevention (CDC) Sexually transmitted diseases treatment guidelines, 20110 MMWR Recomm Rep 59 RR-12 2010 1 110
226. D. Hubacher, R. Lara-Ricalde, D.J. Taylor, F. Guerra-Infante, R. Guzmán-Rodríguez Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women N Engl J Med 345 2001 561 567
227. R. Lyus, P. Lohr, S. Prager Board of the Society of Family Planning Use of the mirena LNG-IUS and paragard CuT380A intrauterine devices in nulliparous women Contraception 81 2010 367 371
228. N. Shimoni Intrauterine contraceptives: A review of uses, side effects, and candidates Semin Reprod Med 28 2010 118 125
229. J.L. Dueñas, A. Albert, F. Carrasco Intrauterine contraception in nulligravid vs parous women Contraception 53 1996 23 24
230. K.L. Fleming, A. Sokoloff, T.R. Raine Attitudes and beliefs about the intrauterine device among teenagers and young women Contraception 82 2010 178 182
231. S.J. Segal, F. Alvarez-Sanchez, C.A. Adejuwon, V. Brache de Mejia, P. Leon, A. Faundes Absence of chorionic gonadotropin in sera of women who use intrauterine devices Fertil Steril 44 1985 214 218
232. I. de Vincenzi A longitudinal study of human immunodeficiency virus transmission by heterosexual partners European study group on heterosexual transmission of HIV N Engl J Med 331 1994 341 346
233. S. McCormack, R. Hayes, C.J. Lacey, A.M. Johnson Microbicides in HIV prevention BMJ 322 2001 410 413
234. D.M. Phillips, K.M. Sudol, C.L. Taylor, L. Guichard, R. Elsen, R.A. Maguire Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs Contraception 70 2004 107 110
235. R. Klein, K. Struble New warning for Nonoxynol 9 OTC contraceptive products re: STDs and HIV/AIDS 2011
236. Nonoxynol 9: Drug Information. Lexicomp, Inc., In: UpToDate. Accessed 2011.
237. C.L. Shandra, A.R. Chowdhury The first sexual experience among adolescent girls with and without disabilities J Youth Adolesc 41 2012 515 532
238. A.I. Alriksson-Schmidt, B.S. Armour, J.K. Thibadeau Are adolescent girls with a physical disability at increased risk for sexual violence? J Sch Health 80 2010 361 367
239. F. Bacopoulou, D.E. Greydanus, G.P. Chrousos Reproductive and contraceptive issues in chronically ill adolescents Eur J Contracept Reprod Health Care 15 2010 389 404
240. ACOG Committee on Practice Bulletins-Gynecology ACOG practice bulletin No. 73: Use of hormonal contraception in women with coexisting medical conditions Obstet Gynecol 107 2006 1453 1472
241. S.E. Perlman, S.J. Rudy, C. Pinto, C. Townsend-Akpan Caring for women with childbearing potential taking teratogenic dermatologic drugs Guidelines for practice J Reprod Med 46 2 Suppl 2001 153 161
242. D.L. Eisenberg, C. Stika, A. Desai, D. Baker, K.J. Yost Providing contraception for women taking potentially teratogenic medications: A survey of internal medicine physicians' knowledge, attitudes and barriers J Gen Intern Med 25 2010 291 297
243. E.B. Schwarz, J. Maselli, M. Norton, R. Gonzales Prescription of teratogenic medications in united states ambulatory practices Am J Med 118 2005 1240 1249
244. J.K. Legardy, K.M. Curtis Progestogen-only contraceptive use among women with sickle cell anemia: A systematic review Contraception 73 2006 195 204
245. M.F. Gallo, L.M. Lopez, D.A. Grimes, K.F. Schulz, F.M. Helmerhorst Combination contraceptives: Effects on weight Cochrane Database Syst Rev 2008 CD003987
246. C. d'Arcangues WHO statement on hormonal contraception and bone health Contraception 73 2006 443 444